CXCL8
Interleukin-8
Also known as: 3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, IL8_HUMAN, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10145
- Gene
- CXCL8
- Ensembl
- ENSG00000169429
- Chromosome
- 4
- Canonical length
- 99 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the CXC chemokine family and is a major mediator of the inflammatory response. The encoded protein is commonly referred to as interleukin-8 (IL-8). IL-8 is secreted by mononuclear macrophages, neutrophils, eosinophils, T lymphocytes, epithelial cells, and fibroblasts. It functions as a chemotactic factor by guiding the neutrophils to the site of infection. Bacterial and viral products rapidly induce IL-8 expression. IL-8 also participates with other cytokines in the proinflammatory signaling cascade and plays a role in systemic inflammatory response syndrome (SIRS). This gene is believed to play a role in the pathogenesis of the lower respiratory tract infection bronchiolitis, a common respiratory tract disease caused by the respiratory syncytial virus (RSV). The overproduction of this proinflammatory protein is thought to cause the lung inflammation associated with csytic fibrosis. This proinflammatory protein is also suspected of playing a role in coronary artery disease and endothelial dysfunction. This protein is also secreted by tumor cells and promotes tumor migration, invasion, angiogenesis and metastasis. This chemokine is also a potent angiogenic factor. The binding of IL-8 to one of its receptors (IL-8RB/CXCR2) increases the permeability of blood vessels and increasing levels of IL-8 are positively correlated with increased severity of multiple disease outcomes (eg, sepsis). This gene and other members of the CXC chemokine gene family form a gene cluster in a region of chromosome 4q. [provided by RefSeq, May 2020]
Canonical amino-acid sequenceUniProt
99 residues, UniProt reviewed canonical sequence.
>P10145|CXCL8
1 MTSKLAVALL AAFLISAALC EGAVLPRSAK ELRCQCIKTY SKPFHPKFIK ELRVIESGPH
61 CANTEIIVKL SDGRELCLDP KENWVQRVVE KFLKRAENSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CXCL8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 2,989 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 2,989 nTPM
- urinary bladder: 415 nTPM
- appendix: 184 nTPM
- gallbladder: 157 nTPM
- lung: 110 nTPM
- liver: 70 nTPM
Single-cell type
- epididymal basal cells: 12,468 nCPM
- neutrophils: 6,691 nCPM
- cdc: 5,291 nCPM
- monocytes: 3,941 nCPM
- endometrial secretory cells: 2,945 nCPM
- epididymal efferent duct absorptive cells: 2,559 nCPM
Immune cell
- neutrophil: 440 nTPM
- basophil: 1 nTPM
- classical monocyte: 0.4 nTPM
- intermediate monocyte: 0.2 nTPM
- eosinophil: 0.1 nTPM
- total PBMC: 0.1 nTPM
Brain region
- cerebral cortex: 274 nTPM
- pons: 28 nTPM
- choroid plexus: 12 nTPM
- thalamus: 7.5 nTPM
- basal ganglia: 3.2 nTPM
- medulla oblongata: 1.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CXCL8.
Disease | AutoantibodyPubMed
Conditions in which antibodies against CXCL8 are reported. Each links to that disease's full target list.
Showing 0 of 1 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for CXCL8 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
37 publications
- Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection.
1993 · Scand J Immunol · RCR 7.7 · 255 citations - Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia.
1996 · Blood · RCR 5.7 · 181 citations - Interleukin 8 and acute lung injury.
2014 · Arch Pathol Lab Med · RCR 3.6 · 98 citations - Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer.
2006 · Gynecol Oncol · RCR 2.6 · 110 citations - Free and complexed interleukin-8 in blood and bronchial mucosa in asthma.
1997 · Am J Respir Crit Care Med · RCR 2 · 81 citations
Show 20 more of 37 total
- Autoantibodies of inflammatory cytokines as serum biomarkers in OSA patients.
2023 · Clin Chim Acta · RCR 2 · 12 citations - Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity.
2001 · Am J Respir Crit Care Med · RCR 1.7 · 76 citations - Anti-IL-8 autoantibodies in alveolar fluid from patients with the adult respiratory distress syndrome.
1996 · J Immunol · RCR 1.6 · 63 citations - Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders.
1993 · Arch Dermatol · RCR 1.5 · 49 citations - Proinflammatory activity of anti-IL-8 autoantibody:IL-8 complexes in alveolar edema fluid from patients with acute lung injury.
2004 · Am J Physiol Lung Cell Mol Physiol · RCR 1.1 · 53 citations - Sensitive and specific immunoassays to detect rabbit IL-8 and MCP-1: cytokines that mediate leukocyte recruitment to the lungs.
1996 · J Immunol Methods · RCR 1.1 · 36 citations - Anti-interleukin-8 autoantibodies in patients at risk for acute respiratory distress syndrome.
2002 · Crit Care Med · RCR 1.1 · 52 citations - Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer.
2019 · Cancers (Basel) · RCR 1.1 · 25 citations - Anti-interleukin-8 autoantibody:interleukin-8 immune complexes in acute lung injury/acute respiratory distress syndrome.
2008 · Clin Sci (Lond) · RCR 0.9 · 36 citations - Bruton's tyrosine kinase mediates FcγRIIa/Toll-like receptor-4 receptor crosstalk in human neutrophils.
2013 · Am J Respir Cell Mol Biol · RCR 0.8 · 27 citations - Anti-IL-8 autoantibodies and complexes in rheumatoid arthritis: polyclonal activation in chronic synovial tissue inflammation.
1999 · Rheumatol Int · RCR 0.8 · 36 citations - Anti-IL-8 autoantibody:IL-8 immune complexes suppress spontaneous apoptosis of neutrophils.
2007 · Am J Physiol Lung Cell Mol Physiol · RCR 0.8 · 33 citations - Transcriptomic profiling in human mesangial cells using patient-derived lupus autoantibodies identified miR-10a as a potential regulator of IL8.
2017 · Sci Rep · RCR 0.7 · 18 citations - Neutrophil attractant protein-1 interleukin 8 and its autoantibodies in IgA nephropathy.
1996 · Clin Immunol Immunopathol · RCR 0.6 · 21 citations - Anti-IL-8 autoantibodies in alveolar fluid from patients at risk for ARDS and with well-defined ARDS.
1999 · Chest · RCR 0.5 · 20 citations - Anti-interleukin 8 autoantibody:interleukin 8 immune complexes visualized by laser confocal microscopy in injured lung.
2007 · Arch Pathol Lab Med · RCR 0.5 · 22 citations - Interleukin-8 and anti-interleukin-8 autoantibodies in gingival crevicular fluid from patients with periodontitis.
2003 · J Periodontal Res · RCR 0.5 · 16 citations - Analysis of plasma autoantibodies for inflammatory cytokines in patients with first-episode schizophrenia among a Chinese population.
2020 · J Neuroimmunol · RCR 0.5 · 7 citations - Anti-chemokine autoantibody:chemokine immune complexes activate endothelial cells via IgG receptors.
2009 · Am J Respir Cell Mol Biol · RCR 0.4 · 16 citations - New insights into the pathogenesis of severe corticosteroid-dependent asthma.
1996 · J Allergy Clin Immunol · RCR 0.4 · 11 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.86
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- antimicrobial humoral immune response mediated by antimicrobial peptide
- calcium-mediated signaling
- cellular response to fibroblast growth factor stimulus
- cellular response to interleukin-1
- cellular response to lipopolysaccharide
- cellular response to tumor necrosis factor
- chemotaxis
- embryonic digestive tract development
- G protein-coupled receptor signaling pathway
- induction of positive chemotaxis
- inflammatory response
- intracellular signal transduction
- negative regulation of cell adhesion molecule production
- negative regulation of cell population proliferation
- negative regulation of G protein-coupled receptor signaling pathway
- negative regulation of gene expression
- neutrophil activation
- neutrophil chemotaxis
- positive regulation of angiogenesis
- positive regulation of gene expression
- positive regulation of neutrophil chemotaxis
- receptor internalization
- regulation of cell adhesion
- regulation of entry of bacterium into host cell
- response to endoplasmic reticulum stress
- response to molecule of bacterial origin
- signal transduction
- regulation of single stranded viral RNA replication via double stranded DNA intermediate
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CXCL8 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CXCL8 as an antibody target. Whether an autoantibody or antibody against CXCL8 could matter depends on whether native CXCL8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CXCL8 is annotated as secreted, so native CXCL8 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CXCL8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...